
Saturday, March 02, 2024 2:50:30 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ORIC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2025 08:20:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 08:10:07 PM
- ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates • GlobeNewswire Inc. • 05/05/2025 08:05:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/02/2025 08:30:00 PM
- ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/28/2025 08:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/23/2025 08:15:54 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2025 08:10:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2025 08:06:42 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/04/2025 08:30:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/31/2025 08:30:00 PM
- ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/25/2025 08:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/20/2025 08:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/14/2025 08:02:17 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/07/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2025 09:34:22 PM
- ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones • GlobeNewswire Inc. • 02/25/2025 09:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/18/2025 09:20:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2025 09:10:07 PM
- ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates • GlobeNewswire Inc. • 02/18/2025 09:05:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/07/2025 09:30:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 01/27/2025 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:30:21 PM
- ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones • GlobeNewswire Inc. • 01/13/2025 01:05:00 PM
- ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2025 09:15:00 PM
Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM
VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM
North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM
UC Asset Filed for Public Offering of 8% Dividend Preferred Units • UCASU • May 12, 2025 9:55 AM